TABLE 5.

Univariate competing risk regression analysis of clinical factors and 1‐year venous thromboembolic recurrence in cancer patients with catheter‐related thrombosis

Variable	HR (95% CI)	p
Age, years	1.00 (0.97–1.02)	0.73
Sex
Female
Male	1.55 (0.72–3.33)	0.26
Weight, kg	0.99 (0.97–1.00)	0.10
Cancer type
Hematologic
Solid	0.46 (0.20–1.03)	0.06
Concurrent PE	1.09 (0.26–4.61)	0.91
Prior history of VTE
No
Yes	1.23 (0.48–3.17)	0.67
Timing of catheter removal
Anticoagulants started before catheter removed
Catheter was not removed	0.65 (0.13–3.20)	0.60
Catheter removed before anticoagulants started	3.38 (1.36–8.40)	0.009
Anticoagulants prescribed
No
Yes	0.59 (0.26–1.34)	0.21
Catheter reinserted after removal
No
Yes	3.26 (1.33–7.98)	0.01

Note: Boldface indicates statistical significance.

Abbreviations: CI, confidence interval; HR, hazard ratio; PE, pulmonary embolism; VTE, venous thromboembolism.